{"nct_id":"NCT04404283","title":"Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2020-08-20","start_date_type":"ACTUAL","primary_completion_date":"2025-11-18","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11-18","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}